Information  X 
Enter a valid email address

EPIC/TIDM matching 'LEL'

Date
Time Source
Company
Announcement
30 Jan 2014 2:27 pm PRN   Factsheet Lilly (Eli) & Co (LEL) 4th Quarter Earnings
28 Aug 2013 2:20 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Dr Marschall S Runge Elected to Lilly Board of ...
25 Jul 2013 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) Half-yearly Report
08 Jul 2013 3:17 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Form 8-K
08 May 2013 3:06 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Form 8K Filing
07 May 2013 3:22 pm PRN   Factsheet Lilly (Eli) & Co (LEL) CEO Lechleiter to undergo surgery
03 May 2013 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) 1st Quarter Results
  7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Proxy Statements
24 Apr 2013 4:31 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Form 8-K Filing
28 Mar 2013 1:35 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Cancellation of Listing
26 Mar 2013 4:01 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Proxy Statements
  4:00 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Statement re Intention to Cancel Listing of Shares
27 Feb 2013 5:06 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Statement re Intention to Cancel Listing
07 Feb 2013 1:59 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Phase 3 RA Program discontinued for Tabalumab
29 Jan 2013 1:33 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Reports Q4 and Full-Year 2012 Results
24 Jan 2013 6:24 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Miscellaneous - Other SEC Filings
  6:22 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Holding(s) in Company
  6:21 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Form 8-K Filings
  6:19 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Director/PDMR Shareholding
  6:16 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Doc re Proxy Statement
  6:15 pm PRN   Factsheet Lilly (Eli) & Co (LEL) 3rd Quarter Results
  6:13 pm PRN   Factsheet Lilly (Eli) & Co (LEL) 1st Quarter Results
  6:12 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Half-yearly Report
  6:11 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Annual Financial Report
  6:02 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Annual Information Update 2012
  5:39 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Annual Information Update 2011
  5:37 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Annual Information Update 2010
16 Jan 2013 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) Amyvid Approved in European Union
07 Jan 2013 2:11 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Phase III data results for empagliflozin
  2:06 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Additional Phase III Clinical Trials
04 Jan 2013 12:55 pm PRN   Factsheet Lilly (Eli) & Co (LEL) 2012 Financial Guidance;2013 Financial Guidance
20 Dec 2012 6:10 pm PRN   Factsheet Lilly (Eli) & Co (LEL) SEC Settlement Press Release
18 Dec 2012 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) LLY Q1 2013 Dividend, $1.5B Share Repurchase Pr...
  7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) LLY Sets Dates for Financial Guidance & Q4 ...
13 Dec 2012 1:16 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Tabalumab RA Study BCDM Discontinuation
12 Dec 2012 1:13 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Next Steps for Solanezumab
08 Nov 2012 1:30 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Cardiovascular outcome study on Tradjenta® (li...
30 Oct 2012 12:15 pm PRN   Factsheet Lilly (Eli) & Co (LEL) EC approves Cialis - benign prostatic hyperplasia
25 Oct 2012 7:20 am PRN   Factsheet Lilly (Eli) & Co (LEL) 3rd Quarter Results
22 Oct 2012 1:54 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Dula Topline Release
19 Oct 2012 2:01 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Amyvid Recommended for Approval in EU
18 Oct 2012 1:25 pm PRN   Factsheet Lilly (Eli) & Co (LEL) FDA Approves New Use of ALIMTA
16 Oct 2012 1:03 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Declares Q4 2012 Dividend
15 Oct 2012 6:33 pm PRN   Factsheet Lilly (Eli) & Co (LEL) REGARD_trial_ramucirumab
  6:33 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Mechanistic Differences Between FORTEO & Zo...
09 Oct 2012 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) LLY's Results of Phase 3 Solanezumab EXPEDITION...
01 Oct 2012 4:13 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Releases Data from Phase II Ramucirumab T...
25 Sep 2012 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Confirms Date for Q3 2012 Financial Resul...
21 Sep 2012 3:54 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Recommended Indication for Trajenta Type 2 Diab...
  3:45 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Cialis Recommended Treatmt Benign Prostatic Hyp...
06 Sep 2012 3:43 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Announces Results from Lung Cancer Study
24 Aug 2012 5:53 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly's Alimta Patent Upheld by US Court of App...
  1:37 pm PRN   Factsheet Lilly (Eli) & Co (LEL) LLY Announces Results of Trial-Patients with Al...
20 Aug 2012 7:00 am PRN   Factsheet Lilly (Eli) & Co (LEL) FDA Approves Updated Prescribing Info for Tradj...
09 Aug 2012 2:36 pm PRN   Factsheet Lilly (Eli) & Co (LEL) LLY Revises 2012 Reported Guidance
25 Jul 2012 3:21 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Reports Q2 2012 Results, Raises 2012 EPS ...
  2:56 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Jentadueto Receives Approval for Type 2 Diabete...
24 Jul 2012 4:38 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Pharmacokinetic Study Results Released
13 Jul 2012 4:01 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Lilly Confirms Date for Q2 2012 Financial Resul...
11 Jul 2012 1:59 pm PRN   Factsheet Lilly (Eli) & Co (LEL) Pomaglumetad Methionil Endpoint of Clinical Study


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements